Please Wait
Applying Filters...

Annual Sales of Tox21_300265 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 25Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Testopel

02 2Voltaren

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : Testopel

Diclofenac Sodium

arrow
AAPS 2024
Not Confirmed

Brand Name : Testopel

arrow
AAPS 2024
Not Confirmed

Diclofenac Sodium

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2020 Revenue in Millions : 35

2019 Revenue in Millions : 55

Growth (%) : -36

blank

02

Brand Name : Testopel

Diclofenac Sodium

arrow
AAPS 2024
Not Confirmed

03

Brand Name : Voltaren

Diclofenac Sodium

arrow
AAPS 2024
Not Confirmed

Brand Name : Voltaren

arrow
AAPS 2024
Not Confirmed

Diclofenac Sodium

Main Therapeutic Indication : Bone and Joint Diseases

Currency : USD

2017 Revenue in Millions : 69

2016 Revenue in Millions : 101

Growth (%) : -32

blank

04

Brand Name : Voltaren

Diclofenac Sodium

arrow
AAPS 2024
Not Confirmed

Brand Name : Voltaren

arrow
AAPS 2024
Not Confirmed

Diclofenac Sodium

Main Therapeutic Indication : Bone And Joint Diseases

Currency : USD

2018 Revenue in Millions : 58

2017 Revenue in Millions : 69

Growth (%) : -16%

blank

05

Brand Name : Testopel

Diclofenac Sodium

arrow
AAPS 2024
Not Confirmed